Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Nov;31(11):1240-50.
doi: 10.1002/humu.21327.

Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases

Affiliations

Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases

Stuart A Scott et al. Hum Mutat. 2010 Nov.

Abstract

The success of prenatal carrier screening as a disease prevention strategy in the Ashkenazi Jewish (AJ) population has driven the expansion of screening panels as disease-causing founder mutations have been identified. However, the carrier frequencies of many of these mutations have not been reported in large AJ cohorts. We determined the carrier frequencies of over 100 mutations for 16 recessive disorders in the New York metropolitan area AJ population. Among the 100% AJ-descended individuals, screening for 16 disorders resulted in ∼1 in 3.3 being a carrier for one disease and ∼1 in 24 for two diseases. The carrier frequencies ranged from 0.066 (1 in 15.2; Gaucher disease) to 0.006 (1 in 168; nemaline myopathy), which averaged ∼15% higher than those for all screenees. Importantly, over 95% of screenees chose to be screened for all possible AJ diseases, including disorders with lower carrier frequencies and/or detectability. Carrier screening also identified rare individuals homozygous for disease-causing mutations who had previously unrecognized clinical manifestations. Additionally, prenatal testing results and experience for all 16 disorders (n = 574) are reported. Together, these data indicate the general acceptance, carrier frequencies, and prenatal testing results for an expanded panel of 16 diseases in the AJ population.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Net MFI data of representative AJ mutation carriers using the MicroPlex™-xTAG™ assay. Results illustrate: (A) a MSUD carrier, (B) a GSDIa compound heterozygote (Coriell ID: NA11468), (C) an E3 carrier, (D) an USH1F and USH3 double-heterozygote, (E) an HI carrier, and (F) a NM carrier. Mutant allelic ratios (see Supporting Methods) are noted above all heterozygous alleles. MFI: mean fluorescence intensity; WT: wild-type; MUT: mutant.

Comment in

Similar articles

Cited by

References

    1. Abeliovich D, Quint A, Weinberg N, Verchezon G, Lerer I, Ekstein J, Rubinstein E. Cystic fibrosis heterozygote screening in the Orthodox Community of Ashkenazi Jews: the Dor Yesharim approach and heterozygote frequency. Eur J Hum Genet. 1996;4:338–341. - PubMed
    1. Al Sulaiman A, Suliman A, Al Mishari M, Al Sawadi A, Owaidah TM. Knowledge and attitude toward the hemoglobinopathies premarital screening program in Saudi Arabia: population-based survey. Hemoglobin. 2008;32:531–538. - PubMed
    1. American College of Obstetricians and Gynecologists. ACOG committee opinion. Number 298, August 2004. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol. 2004;104:425–428. - PubMed
    1. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 442: Preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet Gynecol. 2009;114:950–953. - PubMed
    1. Anderson SL, Ekstein J, Donnelly MC, Keefe EM, Toto NR, LeVoci LA, Rubin BY. Nemaline myopathy in the Ashkenazi Jewish population is caused by a deletion in the nebulin gene. Hum Genet. 2004;115:185–190. - PubMed

Publication types